Skip to main content
SpringerLink
Log in

Marginal Zone Lymphoma

  • Chapter
  • First Online:
Non-Hodgkin's Lymphoma in Childhood and Adolescence

  • 749 Accesses

Abstract

Data on clinical features, treatment, and outcome of pediatric marginal zone lymphoma (MZL) is still limited. MZL represent a B-NHL subtype which clearly differs from aggressive B-NHL with respect to clinical presentation and the need of treatment intensity. Three subtypes of MZL are defined with nodal MZL (nMZL), extranodal MZL (enMZL), and splenic MZL. The latter subtype is rare in children and adolescents. Nodal MZL occur most commonly in healthy male adolescents and present with limited stage disease. Extra nodal MZL are also most common in the adolescent age group with a less prominent male predominance compared with nMZL. An association with infectious agents, inflammation, autoimmune diseases, and immunodeficiency is observed in enMZL. One third of patients presents with advanced stage of disease. For both nMZL and enMZL, the prognosis is excellent with limited treatment for the vast majority of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Swerdlow SH, et al. WHO classification of tumors of hematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008.

    Google Scholar 

  2. Swerdlow SH, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Zinzani PL. The many faces of marginal zone lymphoma. Hematology Am Soc Hematol Educ Program. 2012;2012:426–32.

    Article  PubMed  Google Scholar 

  4. Ronceray L, et al. Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection. Pediatr Blood Cancer. 2018;65(4).

    Article  CAS  Google Scholar 

  5. Makarova O, et al. Excellent outcome with limited treatment in paediatric patients with marginal zone lymphoma. Br J Haematol. 2017;182(5):735–9.

    Article  PubMed  Google Scholar 

  6. Amitay-Laish I, et al. Paediatric primary cutaneous marginal zone B-cell lymphoma: does it differ from its adult counterpart? Br J Dermatol. 2017;176(4):1010–20.

    Article  CAS  PubMed  Google Scholar 

  7. Collado P, et al. Extranodal marginal zone B cell lymphoma: an unexpected complication in children with Sjogren’s syndrome. Reumatol Clin. 2018;14(4):227–9.

    Article  PubMed  Google Scholar 

  8. Hori D, et al. Pediatric nodal marginal zone lymphoma in a Japanese boy. Pediatr Int. 2017;59(3):358–60.

    Article  PubMed  Google Scholar 

  9. O’Suoji C, et al. Rare pediatric Non-Hodgkin lymphomas: a report from Children’s Oncology Group Study ANHL 04B1. Pediatr Blood Cancer. 2016;63(5):794–800.

    Article  PubMed  CAS  Google Scholar 

  10. Ozawa MG, et al. A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma. Mod Pathol. 2016;29(10):1212–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Lum SH, et al. Successful curative therapy with rituximab and allogeneic haematopoietic stem cell transplantation for MALT lymphoma associated With STK4-mutated CD4+ lymphocytopenia. Pediatr Blood Cancer. 2016;63(9):1657–9.

    Article  PubMed  Google Scholar 

  12. Gabali A, et al. Pediatric extranodal marginal zone B-cell lymphoma presenting as amyloidosis in minor salivary glands: a case report and review of the literature. J Pediatr Hematol Oncol. 2013;35(3):e130–3.

    Article  PubMed  Google Scholar 

  13. Rizzo KA, et al. Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR. Mod Pathol. 2010;23(6):866–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kempf W, et al. Primary cutaneous marginal zone lymphoma in children: a report of 3 cases and review of the literature. Am J Dermatopathol. 2014;36(8):661–6.

    Article  PubMed  Google Scholar 

  15. Ryu M, et al. Pediatric mucosa-associated lymphoid tissue (MALT) lymphoma of lip: a case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(3):393–7.

    Article  PubMed  Google Scholar 

  16. Claviez A, et al. MALT lymphoma in children: a report from the NHL-BFM Study Group. Pediatr Blood Cancer. 2006;47(2):210–4.

    Article  PubMed  Google Scholar 

  17. Mo JQ, et al. MALT lymphoma in children: case report and review of the literature. Pediatr Dev Pathol. 2004;7(4):407–13.

    Article  PubMed  Google Scholar 

  18. Taddesse-Heath L, et al. Marginal zone B-cell lymphoma in children and young adults. Am J Surg Pathol. 2003;27(4):522–31.

    Article  PubMed  PubMed Central  Google Scholar 

  19. van den Brand M, van Krieken JH. Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review. Haematologica. 2013;98(7):1003–13.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Desai A, et al. Long-term course of patients with primary ocular adnexal MALT lymphoma: a large single-institution cohort study. Blood. 2017;129(3):324–32.

    Article  CAS  PubMed  Google Scholar 

  21. Hoh H, et al. MALT lymphoma of the conjunctiva in a 13-year old child--5-year relapse-free follow-up following antibiotic treatment. Klin Monatsbl Augenheilkd. 2016;233(1):79–84.

    CAS  PubMed  Google Scholar 

  22. Park MY, et al. Pediatric primary cutaneous marginal zone B-cell lymphoma treated with intralesional rituximab. Eur J Dermatol. 2010;20(4):533–4.

    PubMed  Google Scholar 

  23. Ghatalia P, et al. Primary cutaneous marginal zone lymphoma associated with juxta-articular fibrotic nodules in a teenager. J Cutan Pathol. 2013;40(5):477–84.

    Article  PubMed  Google Scholar 

  24. Berger F, et al. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood. 2000;95(6):1950–6.

    Article  CAS  PubMed  Google Scholar 

  25. Sovani V, et al. Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings. J Clin Pathol. 2014;67(5):389–95.

    Article  PubMed  Google Scholar 

  26. Mittal N, et al. A unique description of stage IV extranodal marginal zone lymphoma (EMZL) in an adolescent associated with gamma heavy chain disease. Pediatr Blood Cancer. 2015;62(5):905–8.

    Article  CAS  PubMed  Google Scholar 

  27. Hyjek E, Isaacson PG. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto’s thyroiditis. Hum Pathol. 1988;19(11):1315–26.

    Article  CAS  PubMed  Google Scholar 

  28. Hyjek E, Smith WJ, Isaacson PG. Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis. Hum Pathol. 1988;19(7):766–76.

    Article  CAS  PubMed  Google Scholar 

  29. Suarez F, et al. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood. 2006;107(8):3034–44.

    Article  CAS  PubMed  Google Scholar 

  30. Perrone S, et al. Infectious aetiology of marginal zone lymphoma and role of anti-infective therapy. Mediterr J Hematol Infect Dis. 2016;8(1):e2016006.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Ekstrom Smedby K, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008;111(8):4029–38.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Ferreri AJ, Govi S, Ponzoni M. Marginal zone lymphomas and infectious agents. Semin Cancer Biol. 2013;23(6):431–40.

    Article  PubMed  Google Scholar 

  33. Morgner A, et al. Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori. Gastroenterol Clin N Am. 2000;29(3):593–607.

    Article  CAS  Google Scholar 

  34. Kluin PM, et al. Paediatric nodal marginal zone B-cell lymphadenopathy of the neck: a Haemophilus influenzae-driven immune disorder? J Pathol. 2015;236(3):302–14.

    Article  CAS  PubMed  Google Scholar 

  35. Bata BM, et al. Combined intraocular and systemic rituximab for ocular lymphoproliferative disorder with extranodal marginal zone lymphoma-type morphology after heart transplant. J AAPOS. 2018;22(2):159–61.

    Article  PubMed  Google Scholar 

  36. Gibson SE, et al. EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder? Am J Surg Pathol. 2011;35(6):807–15.

    Article  PubMed  Google Scholar 

  37. Aghamohammadi A, et al. Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency. Leuk Lymphoma. 2006;47(2):343–6.

    Article  PubMed  Google Scholar 

  38. Koo M, Ohgami RS. Pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma: recent clinical, morphologic, immunophenotypic, and genetic insights. Adv Anat Pathol. 2017;24(3):128–35.

    Article  PubMed  Google Scholar 

  39. Maeshima AM, et al. Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients. Br J Haematol. 2016;174(6):923–31.

    Article  CAS  PubMed  Google Scholar 

  40. Attygalle AD, et al. Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction. Blood. 2004;104(10):3343–8.

    Article  CAS  PubMed  Google Scholar 

  41. Caltharp SA, Qayed M, Park SI. Atypical marginal zone hyperplasia is a mimic for lymphoma in pediatric transplant recipients: report of two patients. Pediatr Dev Pathol. 2015;18(5):416–21.

    Article  PubMed  Google Scholar 

  42. Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin’s lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7(3):332–9.

    CAS  PubMed  Google Scholar 

  43. Rosolen A, et al. Revised international pediatric Non-Hodgkin lymphoma staging system. J Clin Oncol. 2015;33(18):2112–8.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Park JY, et al. Bone marrow involvement is rare in superficial gastric mucosa-associated lymphoid tissue lymphoma. Dig Liver Dis. 2016;48(1):81–6.

    Article  PubMed  Google Scholar 

  45. Ayanambakkam A, et al. Extranodal marginal zone lymphoma of the central nervous system. Clin Lymphoma Myeloma Leuk. 2018;18(1):34–37 e8.

    Article  PubMed  Google Scholar 

  46. Fujita N, et al. Results of the Japan Association of Childhood Leukemia Study (JACLS) NHL-98 protocol for the treatment of B-cell non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia in childhood. Leuk Lymphoma. 2011;52(2):223–9.

    Article  CAS  PubMed  Google Scholar 

  47. Gerrard M, et al. Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin’s lymphoma: results of the FAB/LMB 96 international study. Br J Haematol. 2008;141(6):840–7.

    Article  CAS  PubMed  Google Scholar 

  48. Goldman S, et al. Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children’s Oncology Group report. Leukemia. 2013;27(5):1174–7.

    Article  CAS  PubMed  Google Scholar 

  49. Woessmann W, et al. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood. 2005;105(3):948–58.

    Article  CAS  PubMed  Google Scholar 

  50. Wirth A, et al. Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study. Ann Oncol. 2013;24(5):1344–51.

    Article  CAS  PubMed  Google Scholar 

  51. Nam TK, et al. The role of radiotherapy in the treatment of gastric mucosa-associated lymphoid tissue lymphoma. Cancer Res Treat. 2014;46(1):33–40.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Olszewski AJ, Desai A. Radiation therapy administration and survival in stage I/II extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Int J Radiat Oncol Biol Phys. 2014;88(3):642–9.

    Article  PubMed  Google Scholar 

  53. Ruskone-Fourmestraux A, et al. Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: results of a prospective study with a long term follow-up. Radiother Oncol. 2015;117(1):178–82.

    Article  PubMed  Google Scholar 

  54. Fabbri A, et al. Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas. Eur J Haematol. 2014;93(2):129–36.

    Article  CAS  PubMed  Google Scholar 

  55. Suarez AL, et al. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions. J Am Acad Dermatol. 2013;69(3):343 e1–11; quiz 355-6.

    Article  Google Scholar 

  56. Hamilton SN, et al. Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience. Int J Radiat Oncol Biol Phys. 2013;87(4):719–25.

    Article  PubMed  Google Scholar 

  57. Specht L, et al. Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2015;92(1):32–9.

    Article  PubMed  Google Scholar 

  58. Vandersee S, et al. Treatment of indolent primary cutaneous B-cell lymphomas with subcutaneous interferon-alfa. J Am Acad Dermatol. 2014;70(4):709–15.

    Article  CAS  PubMed  Google Scholar 

  59. Wilcox RA. Cutaneous B-cell lymphomas: 2018 update on diagnosis, risk-stratification, and management. Am J Hematol. 2018;93: 1427–30.

    Article  PubMed  Google Scholar 

  60. Penate Y, et al. Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma. Br J Dermatol. 2012;167(1):174–9.

    Article  CAS  PubMed  Google Scholar 

  61. Kyrtsonis MC, et al. Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab. Eur J Haematol. 2006;77(4):300–3.

    Article  CAS  PubMed  Google Scholar 

  62. Kerl K, et al. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases. Br J Dermatol. 2006;155(6):1197–200.

    Article  CAS  PubMed  Google Scholar 

  63. Park HH, et al. Treatment outcome and risk analysis for cataract after radiotherapy of localized ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma. Radiat Oncol J. 2017;35(3):249–56.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Ferreri AJ, et al. Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas. Ophthalmology. 2011;118(1):24–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Hematology and Oncology, University Hospital Münster, Münster, Germany

    Birgit Burkhardt

Authors
  1. Birgit Burkhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Birgit Burkhardt .

Editor information

Editors and Affiliations

  1. University of Toronto, The Hospital for Sick Children, Toronto, ON, Canada

    Oussama Abla

  2. Medical University of Vienna, St. Anna Children’s Hospital, Vienna, Wein, Austria

    Andishe Attarbaschi

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Burkhardt, B. (2019). Marginal Zone Lymphoma. In: Abla, O., Attarbaschi, A. (eds) Non-Hodgkin's Lymphoma in Childhood and Adolescence. Springer, Cham. https://doi.org/10.1007/978-3-030-11769-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-11769-6_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-11768-9

  • Online ISBN: 978-3-030-11769-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation